{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dronedarone", "query": { "intervention": "Dronedarone" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 12, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dronedarone&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T09:41:11.196Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01198873", "title": "Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atrial Fibrillation" ], "interventions": [ { "name": "Dronedarone", "type": "DRUG" }, { "name": "Placebo (for Dronedarone)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 76, "start_date": "2010-09", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2013-02-12", "last_synced_at": "2026-09-02T09:41:11.196Z", "location_count": 56, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Beverly Hills, California + 51 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Merced", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01198873" }, { "nct_id": "NCT01522651", "title": "Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atrial Fibrillation" ], "interventions": [ { "name": "Ranolazine", "type": "DRUG" }, { "name": "Dronedarone", "type": "DRUG" }, { "name": "Ranolazine placebo", "type": "DRUG" }, { "name": "Dronedarone placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 134, "start_date": "2012-01-24", "completion_date": "2014-03-10", "has_results": true, "last_update_posted_date": "2020-11-06", "last_synced_at": "2026-09-02T09:41:11.196Z", "location_count": 15, "location_summary": "Beverly Hills, California • Newport Beach, California • San Francisco, California + 12 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01522651" }, { "nct_id": "NCT01135017", "title": "Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atrial Fibrillation" ], "interventions": [ { "name": "Dronedarone", "type": "DRUG" }, { "name": "Placebo (for Dronedarone)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 112, "start_date": "2010-07", "completion_date": "2012-02", "has_results": true, "last_update_posted_date": "2013-04-11", "last_synced_at": "2026-09-02T09:41:11.196Z", "location_count": 92, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 79 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01135017" }, { "nct_id": "NCT00489736", "title": "Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrial Fibrillation" ], "interventions": [ { "name": "dronedarone (SR33589)", "type": "DRUG" }, { "name": "amiodarone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 504, "start_date": "2007-06", "completion_date": "2008-10", "has_results": true, "last_update_posted_date": "2010-02-18", "last_synced_at": "2026-09-02T09:41:11.196Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00489736" }, { "nct_id": "NCT04704050", "title": "Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atrial Fibrillation", "Atrial Fibrillation Recurrent" ], "interventions": [ { "name": "dronedarone 400 mg Oral Tablet", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tulane University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2021-05-15", "completion_date": "2022-12-20", "has_results": true, "last_update_posted_date": "2025-10-30", "last_synced_at": "2026-09-02T09:41:11.196Z", "location_count": 4, "location_summary": "Colorado Springs, Colorado • Atlanta, Georgia • New Orleans, Louisiana + 1 more", "locations": [ { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04704050" }, { "nct_id": "NCT04037397", "title": "First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrial Fibrillation" ], "interventions": [ { "name": "Anti Arrhythmics", "type": "DRUG" }, { "name": "Pulmonary Vein Isolation performed by Radio Frequency Catheter Ablation", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2019-09-24", "completion_date": "2024-10-01", "has_results": false, "last_update_posted_date": "2024-11-12", "last_synced_at": "2026-09-02T09:41:11.196Z", "location_count": 5, "location_summary": "Tucson, Arizona • The Bronx, New York • Cleveland, Ohio + 1 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "The Bronx", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04037397" }, { "nct_id": "NCT00911508", "title": "Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atrial Fibrillation", "Arrhythmia" ], "interventions": [ { "name": "Left atrial ablation", "type": "DEVICE" }, { "name": "Rate or Rhythm Control Therapy", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 2204, "start_date": "2009-11-13", "completion_date": "2017-12-31", "has_results": true, "last_update_posted_date": "2021-04-21", "last_synced_at": "2026-09-02T09:41:11.196Z", "location_count": 76, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Sacramento, California + 66 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00911508" }, { "nct_id": "NCT00174785", "title": "A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrial Fibrillation", "Atrial Flutter" ], "interventions": [ { "name": "dronedarone (SR33589)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "70 Years", "maximum_age": null, "sex": "ALL", "summary": "70 Years and older" }, "enrollment_count": 4628, "start_date": "2005-06", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2010-01-12", "last_synced_at": "2026-09-02T09:41:11.196Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00174785" }, { "nct_id": "NCT06096337", "title": "Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Persistent Atrial Fibrillation" ], "interventions": [ { "name": "FARAPULSE™ Pulsed Field Ablation (PFA) System", "type": "DEVICE" }, { "name": "Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 484, "start_date": "2023-12-28", "completion_date": "2028-02-04", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-02T09:41:11.196Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Jonesboro, Arkansas + 38 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06096337" }, { "nct_id": "NCT00259376", "title": "American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrial Fibrillation", "Atrial Flutter" ], "interventions": [ { "name": "Dronedarone (SR33589)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 629, "start_date": "2001-11", "completion_date": "2003-09", "has_results": false, "last_update_posted_date": "2010-02-15", "last_synced_at": "2026-09-02T09:41:11.196Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00259376" } ] }